Hasil Pencarian - Ganessan Kichenadasse

  • Menampilkan 1 - 20 hasil dari 20
Perbaiki Hasil
  1. 1
    Sorafenib-related generalized eruptive keratoacanthomas (Grzybowski syndrome): a case report

    Sorafenib-related generalized eruptive keratoacanthomas (Grzybowski syndrome): a case report oleh M. Nazim Abbas, Wei Son Tan, Ganessan Kichenadasse

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    C-reactive protein provides superior prognostic accuracy than the IMDC risk model in renal cell carcinoma treated with Atezolizumab/Bevacizumab

    C-reactive protein provides superior prognostic accuracy than the IMDC risk model in renal cell carcinoma treated with Atezolizumab/Bevacizumab oleh Ahmad Y. Abuhelwa, Joaquim Bellmunt, Ganessan Kichenadasse, Ganessan Kichenadasse, Ross A. McKinnon, Andrew Rowland, Michael J. Sorich, Ashley M. Hopkins

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Early tumor shrinkage identifies long-term disease control and survival in patients with lung cancer treated with atezolizumab

    Early tumor shrinkage identifies long-term disease control and survival in patients with lung cancer treated with atezolizumab oleh Ashley M Hopkins, Ganessan Kichenadasse, Chris S Karapetis, Michael J Sorich

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Predictors of anti-VEGF drug-induced hypertension using different hypertension criteria: a secondary analysis of the COMPARZ study

    Predictors of anti-VEGF drug-induced hypertension using different hypertension criteria: a secondary analysis of the COMPARZ study oleh Arduino A. Mangoni, Ganessan Kichenadasse, Andrew Rowland, Michael J. Sorich

    Diterbitkan 2018-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Risk factors for severe rash with use of vemurafenib alone or in combination with cobimetinib for advanced melanoma: pooled analysis of clinical trials

    Risk factors for severe rash with use of vemurafenib alone or in combination with cobimetinib for advanced melanoma: pooled analysis of clinical trials oleh Ashley M. Hopkins, Akash D. Rathod, Andrew Rowland, Ganessan Kichenadasse, Michael J. Sorich

    Diterbitkan 2020-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    The Influence of Pre-Existing Beta-Blockers Use on Survival Outcomes in HER2 Positive Advanced Breast Cancer: Pooled Analysis of Clinical Trial Data

    The Influence of Pre-Existing Beta-Blockers Use on Survival Outcomes in HER2 Positive Advanced Breast Cancer: Pooled Analysis of Clinical Trial Data oleh Natansh D. Modi, Jin Quan Eugene Tan, Andrew Rowland, Bogda Koczwara, Bogda Koczwara, Ganessan Kichenadasse, Ganessan Kichenadasse, Ross A. McKinnon, Michael D. Wiese, Michael J. Sorich, Ashley M. Hopkins

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Protocol for the Flinders Kidney Health Registry: patient outcomes of kidney cancers and nephrectomies

    Protocol for the Flinders Kidney Health Registry: patient outcomes of kidney cancers and nephrectomies oleh Jordan Y. Li, Sarah Bodda, Alex Jay, Ganessan Kichenadasse, Michael Chong, Jonathan M. Gleadle, Michael O’Callaghan

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Risk factors for MEK-associated retinopathy in patients with advanced melanoma treated with combination BRAF and MEK inhibitor therapy

    Risk factors for MEK-associated retinopathy in patients with advanced melanoma treated with combination BRAF and MEK inhibitor therapy oleh Andrew E. C. Booth, Ashley M. Hopkins, Andrew Rowland, Ganessan Kichenadasse, Justine R. Smith, Michael J. Sorich

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Clinical and functional outcomes for risk‐appropriate treatments for prostate cancer

    Clinical and functional outcomes for risk‐appropriate treatments for prostate cancer oleh Tenaw Tiruye, Michael O'Callaghan, Kerry Ettridge, Kim Moretti, Alex Jay, Braden Higgs, Kerry Santoro, Ganessan Kichenadasse, Kerri Beckmann

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Targeted pharmacotherapy after somatic cancer mutation screening [version 2; referees: 2 approved]

    Targeted pharmacotherapy after somatic cancer mutation screening [version 2; referees: 2 approved] oleh Thomas M. Polasek, Karen Ambler, Hamish S. Scott, Michael J. Sorich, Peter A. Kaub, Andrew Rowland, Michael D. Wiese, Ganessan Kichenadasse

    Diterbitkan 2016-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    381 SUPLEXA, a multimodal autologous cellular therapy, shows immunomodulatory behavior in cancer patients consistent with improved anti-tumor immune function

    381 SUPLEXA, a multimodal autologous cellular therapy, shows immunomodulatory behavior in cancer patients consistent with improved anti-tumor immune function oleh Rohit Joshi, Sharron Gargosky, Ganessan Kichenadasse, James A Lederer, Jeffrey Goh, Frank Borriello, John F Pulford, Ekaterina Murzin, Daniel Younger

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Cost-effectiveness of oral anticancer drugs and associated individualised dosing approaches in patients with cancer: protocol for a systematic review

    Cost-effectiveness of oral anticancer drugs and associated individualised dosing approaches in patients with cancer: protocol for a systematic review oleh Billingsley Kaambwa, Nikki May, Ganessan Kichenadasse, Robin Michelet, Madelé van Dyk, Norma Bulamu, Chelsea Boylan, Anna M Mc Laughlin, Charlotte Kloft

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    SRRM4 Expands the Repertoire of Circular RNAs by Regulating Microexon Inclusion

    SRRM4 Expands the Repertoire of Circular RNAs by Regulating Microexon Inclusion oleh Vanessa M. Conn, Marta Gabryelska, Shashikanth Marri, Brett W. Stringer, Rebecca J. Ormsby, Timothy Penn, Santosh Poonnoose, Ganessan Kichenadasse, Simon J. Conn

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Nuances to precision dosing strategies of targeted cancer medicines

    Nuances to precision dosing strategies of targeted cancer medicines oleh Ashley M. Hopkins, Bradley D. Menz, Michael D. Wiese, Ganessan Kichenadasse, Howard Gurney, Ross A. McKinnon, Andrew Rowland, Michael J. Sorich

    Diterbitkan 2020-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials

    A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials oleh Lee X. Li, Mark A. Socinski, Ganessan Kichenadasse, Christos S. Karapetis, Adel Shahnam, Ross A. McKinnon, Andrew Rowland, Ashley M. Hopkins, Michael J. Sorich

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Predicting chemotherapy‐induced menopause using baseline and post‐chemotherapy anti‐Müllerian hormone levels: Results of a pilot study

    Predicting chemotherapy‐induced menopause using baseline and post‐chemotherapy anti‐Müllerian hormone levels: Results of a pilot study oleh Hilary Laura Martin, Shahid Ullah, Nazim Abbas, Alex Scott‐Hoy, Ganessan Kichenadasse, Christos Stelios Karapetis, Amitesh Roy, Shawgi Sukumaran, David M Ross, Muhammad Adnan Khattak, Bogda Koczwara

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data

    The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data oleh Natansh D. Modi, Jin Quan Eugene Tan, Andrew Rowland, Bogda Koczwara, Ahmad Y. Abuhelwa, Ganessan Kichenadasse, Ross A. McKinnon, Michael D. Wiese, Michael J. Sorich, Ashley M. Hopkins

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Usability, Acceptability, and Safety Analysis of a Computer-Tailored Web-Based Exercise Intervention (ExerciseGuide) for Individuals With Metastatic Prostate Cancer: Multi-Methods Laboratory-Based Study

    Usability, Acceptability, and Safety Analysis of a Computer-Tailored Web-Based Exercise Intervention (ExerciseGuide) for Individuals With Metastatic Prostate Cancer: Multi-Methods... oleh Holly EL Evans, Cynthia C Forbes, Daniel A Galvão, Corneel Vandelanotte, Robert U Newton, Gary Wittert, Suzanne Chambers, Andrew D Vincent, Ganessan Kichenadasse, Danielle Girard, Nicholas Brook, Camille E Short

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Evaluating a web- and telephone-based personalised exercise intervention for individuals living with metastatic prostate cancer (ExerciseGuide): protocol for a pilot randomised controlled trial

    Evaluating a web- and telephone-based personalised exercise intervention for individuals living with metastatic prostate cancer (ExerciseGuide): protocol for a pilot randomised con... oleh Holly E. L. Evans, Cynthia C. Forbes, Daniel A. Galvão, Corneel Vandelanotte, Robert U. Newton, Gary Wittert, Suzanne Chambers, Andrew D. Vincent, Ganessan Kichenadasse, Nicholas Brook, Danielle Girard, Camille E. Short

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies

    A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies oleh Natansh D. Modi, Ganessan Kichenadasse, Tammy C. Hoffmann, Mark Haseloff, Jessica M. Logan, Areti A. Veroniki, Rebecca L. Venchiarutti, Amelia K. Smit, Haitham Tuffaha, Harindra Jayasekara, Arkady Manning-Bennet, Erin Morton, Ross A. McKinnon, Andrew Rowland, Michael J. Sorich, Ashley M. Hopkins

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: